Clinical Trial Update: A Phase I Study OfLNF2007 Monotherapy in Patients with Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase I study of LNF2007 as monotherapy in patients with advanced solid tumors is not yet recruiting. Sponsor: Shandong New Time Pharmaceutical Co., LTD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• LNF2007

Snippet

Sponsor: Shandong New Time Pharmaceutical Co., LTD | Conditions: Advanced Solid Tumors (Phase 1) | Phase 1 | Status: NOT_YET_RECRUITING